5 studies found for:    QTI571
Show Display Options
Rank Status Study
1 Active, not recruiting Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan
Condition: Severe Pulmonary Arterial Hypertension
Intervention: Drug: QTI571
2 Completed Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Imatinib
3 Completed
Has Results
Imatinib (QTI571) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: imatinib mesylate;   Drug: Placebo
4 Active, not recruiting Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Imatinib
5 Active, not recruiting Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: imatinib

Indicates status has not been verified in more than two years